Embed Size (px)
Citation preview
News Bulletin
No. 23 June 20171Nation1Cluster
Editorial Christoph Besmer, Trade Commissioner of SwitzerlandIt is with great pleasure that we welcome the Swiss Biotech As-sociation and all participants of the Swiss Pavilion at this year’s BIO International Convention in San Diego, California. With breakthrough technology com-
panies and research organizations, the largest military concentration in the world and a strong tourism industry, the San Diego region has one of the most diverse, dynamic economies in the country. The life sciences cluster is a major driver of San Diego’s innovation economy. The region is home to more than 1,100 life sciences companies and more than 80 independent and university-affiliated research institutes. Life sci-ences activity accounts for more than $31.8 billion in total economic impact in San Diego.
The Swiss Business Hub USA is the representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). We provide localized support, consulting and networking services to Swiss companies venturing into the US market. A key area of our interest and expertise lies in the biotech sector. An experienced team stands ready to support your inquiries of all kind and serves as a first-hand local contact in the US market. Our services include: market information and support; fundraising support, search for distributors, local representatives and partners; B2B / B2C sales pipeline development; individual consulting and coaching; as well as site location evaluation; organization of events and fact-finding missions. We are looking forward to explore possible areas of collaboration.
We are pleased to have you as our guests during the Swiss Biotech networking event to be held on Tuesday, June 20, 2017. I wish you a successful conference and a pleasant stay in San Diego.
NTN partners: Project partner:
Contents• Program: Swiss Biotech™
@ BIO 2017 In San Diego• Swiss Biotech Report 2017• Participating Companies and
Institutions• Antibody Drug Conjugates• Opening of the SwissFEL• Biopôle Services
Program: Swiss Biotech™ @ BIO 2017 in San DiegoMonday, June 19
BIO Special Program and Education Sessions - SWISS Pavilion: 2305 (set-up)
Tuesday, June 20
7:00 am – 5:30 pm BIO One-on-One Partnering Meetings
10:30 am – 5:00 pm Exhibition hours – SWISS Pavilion 2305
18.00 pm Networking Reception for Swiss Delegation and invited guests at Tom Ham’s Lighthouse
Wednesday, June 21
7:00 am – 5:30 pm BIO One-on-One Partnering Meetings
10:30 am – 5:00 pm Exhibition hours – SWISS Pavilion 2305
15:00 pm Switzerland – Global Innovation Hub presentation
Thursday, June 22
7:00 am – 4:30 pm BIO One-on-One Partnering Meetings
10:30 am – 4:30 pm Exhibition hours – SWISS Pavilion 2305
Swiss Biotech Report 2017
www.swissbiotechreport.ch
Swiss Biotech Report 2017:Claim your copy at the Swiss PavilionBiotechnology will continue to play a key role in the sustainable development of Swit-zerland and contributes to the largest export sector. Boosting innovation in this industry will be vital to economic growth, to our environmental endeavours, to commercialization of new technologies and to public health. By further strengthening academic output, enablers and competitive clusters, we can create a strong ’bioeconomy’ moving forward. The current report highlights major initiatives and key players in the value proposition,
and looks at the contribution they make to its success. Download a copy at: www.swissbiotechreport.ch
Invitation: Swiss Business Hub USA BIO 2017 networking receptionTuesday, June 20, 2017
Please join us for an informal reception welcoming Swiss and American life science execu-tives, as well as key industry multipliers to BIO 2017.
Where: Tom Ham’s Lighthouse (www.tomhamslighthouse.com) 2150 Harbor Island Drive, San Diego, CA 92101
When: From 6 to 9 PM
Please RSVP: Via the following link: https://switzerland-bio2017.splashthat.com
Further questions Please contact Christoph Besmer, Trade Commissioner, at [email protected]
Company Company description Name Phone E-Mail Website
AC Immune SA AC Immune develops innovative therapeutics and diagnostics for Alzheimer’s and other neurodegenera-tive diseases.
Prof. Andrea Pfeifer +41 21 345 91 21 [email protected] www.acimmune.com
Bachem AG Bachem provides a full range of services to the pharma and biotech industries. It specializes in the de-velopment of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients.
Ms. Elza Lopes +41 58 595 2021 [email protected] www.bachem.com
BioAlps Your entry point to a wealth of contacts, know-how and knowledge, for both personal and institutional support: BioAlps, the life science cluster of Western Switzerland.
Mr. Claude Joris +41 22 604 4049 [email protected] www.bioalps.org
Biopôle SA Biopôle is a unique life science park hosting a vibrant community of industry players and research insti-tutes, based in Lausanne at the heart of the Swiss Health Valley.
Mr. Nasri Nahas +41 21 651 90 00 [email protected] www.biopole.ch
Biotechnet biotechnet Switzerland helps you access a wide variety of high-caliber competencies in biotechnology of Swiss Universities of Applied Sciences, Universities and Research and Technology Organizations.
Prof. Dr. Laura Sut-er-Dick
+41 61 467 42 42 [email protected] www.biotechnet.ch
BÜHLMANN Laboratories AG BÜHLMANN develops, manufactures and distributes worldwide in vitro diagnostic tests in the fields of Gastroenterology, Neuroimmunology and Allergy.
Dr. Thomas Hafen +41 61 487 12 12 [email protected] www.buhlmannlabs.ch
Cerbios-Pharma SA Cerbios-Pharma SA is a privately held company specialized in the development and manufacturing of chemical and biological API's. Services are offered in the area of HPAls and Biopharmaceuticals
Ms. Mara Camillo +41 79 618 0988 [email protected] www.cerbios.ch
CSL Behring AG CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies to treat people with life-threatening medical conditions.
+41 31 344 44 44 [email protected] www.cslbehring.ch
Greater Zürich Area We support business expansions into the greater zurich area. Mr. Douglas Karl Ebert +1 859 372 67 60 [email protected] www.greaterzuricharea.com
leadXpro AG LeadXpro applies structure-based drug discovery to membrane protein targets to discover new com-pounds in its own oncology and antibacterial programs, and with partners seeking novel lead molecules.
Prof. Dr. Michael Hennig +41 79 770 97 24 [email protected] www.leadxpro.com
Life Science Zurich Business Network
The LSZ Business Network promotes cooperations between Life Science stakeholders in academia, industry and the public sector.
Dr. Isabel Klusman +41 44 633 87 11 [email protected] www.lifescience-businessnetwork.ch
Molecular Partners AG Molecular Partners create medicines using a novel class of biologicals (DARPins) for diseases with unmet medical needs.
Dr. Patrick Amstutz +41 44 755 7700 [email protected] www.molecularpartners.com
National Thematic Network (NTN) Swiss Biotech
biotechnet and Swiss Biotech Association (SBA) are founders and members of the CTI National Thematic Network joining the biotech competencies of Swiss academia with the innovation potential of Swiss bio-tech companies.
Ms. Cathy Kroll / Mr. Daniel Gygax
+41 44 455 56 78 [email protected] www.swissbiotech.org
PRECLIN Biosystems AG Comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.
Ms. Bettina Erns + 41 44 586 0776 [email protected] www.preclinbiosystems.com
SICPA Securink Corp. We offer overt and covert high security inks for banknotes, value documents, and brand protection. Ms. Carrie Hannigan +1 703 455 80 50 [email protected] www.sicpa.com
Sulzer Mixpac AG Leading packaging, mixing and dispensing solutions for pharma and healthcare applications globally. Mr. Daniel Strasser +41 79 427 73 41 [email protected] www.sulzer.com
Swiss Biotech Association The Swiss Biotech Association represents the interests of the biotech sector, supports the biotech com-panies, and generates value for members and the industry.
Mr. Jean-Marc Tissot +41 44 455 5678 [email protected] www.swissbiotech.org
Swiss Business Hub The Swiss Business Hub USA, as the official antenna of Switzerland Global Enterprise in the United States, provides local support, market information, consulting and networking services to Swiss compan-ies venturing into the US market. An experienced team of stands ready to support inquiries of all kind and serves as a contact for companies - new or experienced.
Mr. Dan Bangser +1 917 289 9932 [email protected] www.s-ge.com/en/company/swiss-business-hub-usa
swiTT The Swiss Technology Transfer Association (swiTT) is the association of technology transfer professionals active in the transfer of technology from institutes of public research and education, university hospitals, and other not-for-profit research organizations to the private sector.
Mr. Michel Dreano +41 79 909 59 76 [email protected] www.switt.ch
Switzerland Innovation Switzerland Innovation operates five regional research and innovation parks in Switzerland and a foun-dation funded by 19 renowned Swiss companies and trade associations that is responsible for further developments in the site portfolio.
Mr. Raymond Cron +41 31 382 52 17 [email protected] www.switzerland-innovation.com
Tillotts Pharma AG Tillotts Pharma AG is a specialty pharma company dedicated to expanding its footprint through the de-velopment, marketing, in-licensing and acquisition of innovative pharmaceutical products for the digestive system.
Ms. Julie Delin Fosdal +41 61 935 2626 [email protected] www.tillotts.com
Venture Valuation AG Venture Valuation specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology. Further more, the company runs the global life science Database Biotechgate (www.biotechgate.com) as a subscription service.
Dr. Patrik Frey +41 43 321 86 60 [email protected] www.venturevaluation.com
Wyss Zürich Wyss Zurich fosters the clinical translation and technology transfer of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the emerging fields of Regenerative Medi-cine and Robotics.
Ms. Cathrin Gutwald +41 44 632 61 64 [email protected] www.WyssZurich.uzh.ch
BIO International Convention 2017 in San Diego, June 19-22, 2017 SWISS Pavilion – booth no. 2305
Antibody Drug Conjugates: Cerbios joined CMC Biologics and IDT Biologika in their strategic collaboration offering a fully integrated service to his partnersCMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika GmbH, a privately-held life-science company with a 95 year history of expertise in research, development and manu-facture of biologics for human and animal health, announced at the end of 2016 the addition of Cerbios-Pharma SA (“Cerbios”) and Oncotec Pharma Produktion GmbH (“Oncotec“) to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of antibody drug conjugate (ADCs).
Within the PROVEO collaborative partnership, CMC Biologics provides monoclonal antibody production, Cerbios performs process development and manufacture of the cytotoxic drug-linker payload, and the conjugation services of the ADC drug substance. Oncotec provides aseptic fill and lyophilization of the ADC drug product, and IDT Biologika performs analytical and quality services, supply chain and secondary packaging through to ready-to-deliver final drug product. These services are now available and further complete PROVEO’s full ADC service offering.
The opening of the SwissFEL (Free Electron Laser)Johann N. Schneider-Ammann, President of the Swiss Con-federation, and PSI Director Joël Mesot inaugurating first light at the SwissFEL in Dec 2016 (Photo: Paul Scherrer Institute/Markus Fischer). Together with cryo-Electron Microscopy technology and serial crystallography, SwissFEL forms a crucial pillar for leadXpro’s structure-based drug discovery research. SwissFEL will provide unprecedented insights into protein-ligand interaction analysis at atomic resolution to develop new and highly specific lead molecules. LeadXpro partners with pharma and biotech companies to unlock new drug discovery options for membrane protein targets. (Source: leadXpro AG)
Contact: NTN-SwissBiotechEditor C. Kroll - [email protected] H. Bihlman - [email protected] 3 times a year (print or pdf.)
Main Office, ZürichSwiss Biotech AssociationStauffacherstrasse 16 8004 Zürich
Office RomandieSwiss Biotech AssociationRue Haldimand 151003 Lausanne
